ARGLU1

ARGLU1 is a bifunctional nuclear protein that couples alternative pre-mRNA splicing to transcriptional regulation (PMID:30698747, PMID:27899669). Its arginine-rich N-terminus binds RNA and splicing factors, while its glutamate-rich C-terminus coactivates nuclear receptors including the glucocorticoid receptor (PMID:30698747); the latter activity is executed in part through direct interaction with the Mediator subunit MED1, with which ARGLU1 colocalizes and is recruited in a ligand-dependent manner to estrogen receptor target gene promoters to regulate transcription (PMID:21454576). ARGLU1 autoregulates its own expression by promoting intron retention and NMD-susceptible isoforms of its own transcript through an ultraconserved element in the retained intron, a feedback circuit that is relieved by an ARGLU1-derived stable intronic sequence RNA that binds the protein and sequesters it in nuclear speckles (PMID:27899669, PMID:36533631). Loss of ARGLU1 drives genome-wide splicing changes and is embryonic lethal in mice, and in developing cortex its ablation mis-splices Mdm2 and Mdm4 to remove their p53-binding domains, relieving p53 repression and causing radial glial detachment, apoptosis, and microcephaly that is rescued by p53 removal (PMID:30698747, PMID:37612280). ARGLU1 also enhances promoter-proximal RNA polymerase II pausing, by inhibiting the JMJD6–BRD4 interaction, and promotes DNA damage repair, contributing to genotoxic-drug resistance in cancer cells (PMID:38520408). Its protein levels are controlled by K11-linked ubiquitination and degradation via the DTL/CRL4A E3 ligase (PMID:38218284).

1. 2011 High

   Established ARGLU1 as a transcriptional coactivator by placing it physically within the nuclear receptor–Mediator axis, answering how it influences hormone-responsive gene expression.

   Evidence Co-IP, GST pulldown, ChIP/ChIP-reChIP and reporter assays in estrogen receptor signaling

   PMID:21454576

   Open questions at the time

   • Did not define the splicing arm of ARGLU1 function
   • MED1-binding interface on ARGLU1 not mapped at residue resolution
2. 2017 High

   Revealed that ARGLU1 autoregulates its own abundance by shifting its mRNA toward intron-retained, NMD-targeted isoforms through an ultraconserved element, defining a homeostatic feedback loop.

   Evidence CRISPR UCE mutation, minigene reporters, and overexpression/knockout isoform analysis

   PMID:27899669

   Open questions at the time

   • The trans-acting splicing factors recruited at the UCE were not identified
   • Did not establish whether autoregulation operates in vivo
3. 2019 High

   Resolved ARGLU1 as a two-domain bifunctional protein—C-terminus coactivating nuclear receptors, N-terminus binding RNA/splicing factors—and demonstrated its essentiality for development.

   Evidence Domain mapping, RNA-seq, siRNA, mouse knockout, and zebrafish morpholino knockdown

   PMID:30698747

   Open questions at the time

   • Direct splicing-factor partners not individually validated
   • Causal link between specific splicing targets and developmental phenotypes left open
4. 2022 Medium

   Identified a regulatory RNA loop in which an ARGLU1-derived sisRNA binds the protein and relocates it to nuclear speckles, explaining how ARGLU1's splicing-inhibitory activity on its own host gene is dampened.

   Evidence RNA-protein binding assays, fluorescence localization, and functional splicing readouts

   PMID:36533631

   Open questions at the time

   • Single lab; sisRNA binding site on ARGLU1 protein not mapped
   • Generality of speckle sequestration beyond the host gene unknown
5. 2021 Medium

   Connected ARGLU1 to DNA mismatch repair gene expression, showing it potentiates SP1/YY1 recruitment to MMR promoters.

   Evidence Overexpression/knockdown with ChIP for SP1 and YY1 at MMR promoters

   PMID:34157484

   Open questions at the time

   • Single lab; direct ARGLU1-SP1/YY1 interaction not demonstrated
   • Whether effect is transcriptional vs splicing-mediated not separated
6. 2023 High

   Provided in vivo mechanism for ARGLU1's developmental essentiality by showing its splicing of Mdm2/Mdm4 controls p53 activity, with p53 deletion rescuing microcephaly.

   Evidence Conditional mouse knockout, RNA-seq, isoform validation, and Arglu1×p53 genetic epistasis

   PMID:37612280

   Open questions at the time

   • How ARGLU1 recognizes the specific Mdm2/Mdm4 exons not defined
   • Contribution of transcriptional coactivation to this phenotype not assessed
7. 2024 Medium

   Placed ARGLU1 in RNA Pol II pause control and DNA damage repair, linking it to the JMJD6–BRD4 axis and to genotoxic-drug resistance.

   Evidence E1A functional probe, Pol II ChIP, Co-IP, and overexpression/knockdown under genotoxic stress

   PMID:38520408

   Open questions at the time

   • Direct inhibition of JMJD6–BRD4 by ARGLU1 inferred, not biochemically reconstituted
   • Single study
8. 2024 Medium

   Identified how ARGLU1 protein levels are set post-translationally, showing DTL drives K11-linked ubiquitination and degradation, with downstream effects on Notch signaling.

   Evidence Mass spectrometry, Co-IP, ubiquitination assays, and siARGLU1 epistasis rescue in HNSCC

   PMID:38218284

   Open questions at the time

   • Ubiquitination site on ARGLU1 not mapped
   • Single lab; CRL4A complex requirement assumed from DTL
9. 2025 Medium

   Extended ARGLU1's pausing/repair function to viral infection, showing it binds adenovirus E1A and represses viral promoters via Pol II pausing.

   Evidence GST pulldown with recombinant proteins, colocalization, viral promoter Pol II ChIP, and E1A binding-deficient mutant epistasis

   PMID:41186411

   Open questions at the time

   • Single study; host-gene relevance of E1A-ARGLU1 axis not addressed
10. 2025 Low

    Documented miRNA control of ARGLU1, with miR-335-5p and miR-499a-5p directly targeting its transcript to regulate proliferation, apoptosis, and autophagy in disease models.

    Evidence Dual-luciferase reporter assays, western blot, and functional rescue in leiomyoma and cardiomyocyte models

    PMID:35082911 PMID:40694483

    Open questions at the time

    • miR-499a-5p finding not independently confirmed
    • Functional rescue only partially explored
    • Endogenous physiological relevance unclear

• How ARGLU1 integrates its splicing and transcriptional coactivation activities at the same loci, and what determines its target specificity, remains unresolved.
• No structural model of ARGLU1 domains bound to RNA or MED1
• Genome-wide direct RNA/DNA binding sites not mapped
• Mechanism coupling pausing, splicing, and coactivation not unified